Glomus tumor of nail bed - Dermatology Notes

Definition: A benign, hamartomatous neoplasm arising from the glomus body, a specialized thermoregulatory arteriovenous shunt located in the reticular dermis of the digits, particularly the nail bed and subungual region.

Key Clinical Features:

• Demographics: Adults 30–50 years; slight female predominance.

• Location: Subungual or periungual – most common site for glomus tumor in the body (75% of all glomus tumors occur in the hand, with the majority under the nail). The thumb, index, and middle fingers are most frequently affected.

• Classic triad (Lancisi–Palletta–Masson triad):

  • Paroxysmal pain (severe, lancinating, often nocturnal).

  • Extreme tenderness to touch (point tenderness).

  • Cold hypersensitivity (pain triggered or worsened by cold exposure).

• Nail changes: Longitudinal erythronychia (red streak), localized bluish or purple discoloration (visible through the nail plate), nail plate ridging, splitting, or thinning. Rarely, a visible red-blue nodule elevates the nail plate.

• Hildreth sign (board essential): Ischemic compression of the digit proximal to the tumor (tourniquet effect) relieves pain. Release of compression reproduces pain. This is highly specific for glomus tumor.

• Love test (pinpoint tenderness): Using the head of a pin or paperclip, precise localization of the point of maximal tenderness (often as small as 2–3 mm) is diagnostic.

• Cold sensitivity test: Immersion of the hand in cold water precipitates pain.

Associated Conditions/Diseases:

• Multiple glomus tumors (10%): May be sporadic or familial (autosomal dominant). Associated with neurofibromatosis type 1 (rare) and blue rubber bleb nevus syndrome.

• Familial glomangiomatosis: Multiple painful blue nodules; mutations in glomulin (GLMN) gene on chromosome 1p21-22.

• Malignant glomus tumor (glomangiosarcoma): Extremely rare (<1%); characterized by marked cytologic atypia, increased mitotic activity (>5 mitoses per 50 high-power fields), and deep invasion.

Prognosis:

• Excellent with complete surgical excision.

• Recurrence rate: 10–20% (due to incomplete excision, especially with subungual location where complete visualization is difficult).

• Malignant transformation is exceedingly rare.

Differential Diagnosis:

• Subungual exostosis: Hard, bony prominence on dorsal distal phalanx; radiograph shows bony outgrowth; no paroxysmal pain or cold hypersensitivity.

• Subungual melanoma: Pigmented lesion (Hutchinson sign), new or changing, may have ulceration; histology shows atypical melanocytes.

• Subungual verruca: Hyperkeratotic, punctate black dots (thrombosed capillaries), no severe pain or cold sensitivity.

• Epidermal inclusion cyst: Firm, non-tender, slow-growing; no paroxysmal pain.

• Pyogenic granuloma: Friable, bleeding, rapidly growing; history of trauma; no classic triad.

• Subungual neurilemmoma (schwannoma): Rare; similar pain but less cold sensitivity; histology shows Antoni A and B patterns, S100 positive.

• Painful neuroma (post-traumatic): History of digital nerve injury; Tinel sign positive.

Management with Rationale:

1. Surgical excision (gold standard):

   • Transungual approach: Partial or total nail plate removal followed by longitudinal incision through nail bed, microdissection of tumor, and primary repair of nail bed with fine absorbable sutures. Preferred for subungual glomus tumor.

   • Periungual or lateral approach: For tumors located in the lateral nail fold or eponychium.

   • Rationale: Complete excision is curative and relieves symptoms immediately.

2. Preoperative localization: High-resolution ultrasound with Doppler (identifies vascular tumor) or magnetic resonance imaging (MRI) – glomus tumor shows high T2 signal due to vascular spaces.

3. Surgical magnification (loupes or operating microscope): Essential for complete excision and preservation of nail bed.

4. Histopathologic confirmation: All excised tissue must be sent for histology.

5. Recurrent tumors: Re-excision with wider margins; imaging (MRI) to map extent.

Rationale for surgical approach: Glomus tumors are not amenable to medical therapy. Incomplete excision leads to persistent or recurrent symptoms.

Histopathology

1. FOUNDATIONS (First Principles)

• Normal glomus body: A specialized arteriovenous shunt located in the reticular dermis of the digits, palms, soles, and nail beds. Components include:

  • Afferent arteriole.

  • Sucquet–Hoyer canal (anastomotic channel with thick, cuboidal endothelial cells surrounded by multiple layers of contractile glomus cells).

  • Efferent venule.

• Glomus cells (modified smooth muscle cells): Round to cuboidal cells with central round nuclei and pale eosinophilic cytoplasm. They express smooth muscle actin (SMA) and are innervated by unmyelinated C-fibers (mediating pain and temperature sensation).

• Function of glomus body: Thermoregulation – vasoconstriction (cold) and vasodilation (heat) to preserve core body temperature.

2. INITIATING EVENT

• Sporadic (90%): Unknown initiating event; may arise from a single glomus cell or precursor cell that undergoes neoplastic transformation.

• Familial (10%): Germline loss-of-function mutations in the GLMN (glomulin) gene on chromosome 1p21-22 → impaired tumor suppression → development of multiple glomus tumors (glomuvenous malformations).

3. PATHOGENESIS

• Clonal expansion of a transformed glomus cell (or pericyte-like precursor) → proliferation of neoplastic glomus cells around vascular channels.

• Tumor forms a well-circumscribed, encapsulated nodule composed of:

  • Vascular spaces (dilated, thin-walled, lined by flattened endothelium).

  • Cuffs of glomus cells surrounding the vascular spaces.

  • Fibrous capsule separating tumor from surrounding dermis.

• Why pain? Glomus cells are innervated by abundant unmyelinated C-fibers (substance P, CGRP). Tumor expansion compresses these nerve fibers. Cold exposure triggers vasoconstriction of the tumor's vascular spaces → ischemia → release of pain mediators (substance P, bradykinin, prostaglandins).

• Why cold hypersensitivity? The normal glomus body is a thermoreceptor. Neoplastic glomus cells retain this sensory function but respond pathologically to cold with intense vasospasm and pain.

• Why point tenderness? The tumor is highly innervated and encapsulated; even minimal pressure (e.g., a pinhead) deforms the capsule and compresses nerve endings.

4. HISTOPATHOLOGY EXPLAINED

Low power:

• Well-circumscribed, encapsulated nodule located in the reticular dermis (or nail bed dermis, immediately beneath the nail matrix or nail bed epithelium).

• Three histologic variants (Masson classification):

  • Solid glomus tumor (most common – 75%): Sheets or nests of glomus cells with sparse vascular spaces.

  • Glomangioma (20%): Predominantly dilated vascular channels with only small cuffs of glomus cells (resembles cavernous hemangioma).

  • Glomangiomyoma (5%): Mixture of glomus cells, vascular spaces, and smooth muscle bundles.

• Tumor does not involve the epidermis (except by secondary compression or erosion).

High power – glomus cells:

• Round to cuboidal cells with well-defined cell borders.

• Central, round, uniform nucleus (no pleomorphism in benign tumors).

• Eosinophilic to pale-staining cytoplasm (due to glycogen and thin filaments).

• Perinuclear halo (clear space artifact).

• No mitotic figures (in benign glomus tumor; mitoses are extremely rare).

Vascular component:

• Dilated, thin-walled vascular spaces lined by flattened endothelial cells (CD31+, CD34+).

• Lumina may contain red blood cells or thrombi.

• No atypical vessels.

Stroma:

• Fibrous capsule (dense collagen) surrounding the tumor.

• Mast cells are often numerous (may contribute to pain via histamine release).

• Variable myxoid stroma (pale blue-grey on H&E).

Nail bed specific features:

• Tumor is located immediately beneath the nail matrix or nail bed epithelium (squamous epithelium with no granular layer on the ventral surface of the nail plate).

• Compression of the overlying nail bed epithelium may cause thinning, but no invasion.

Why this appearance:

• Well-circumscribed, encapsulated – Glomus tumors are benign and do not infiltrate surrounding dermis.

• Uniform glomus cells – These are neoplastic but well-differentiated modified smooth muscle cells; they retain round nuclei and pale cytoplasm.

• Vascular spaces – The tumor recapitulates the normal glomus body architecture (vascular channels with perivascular glomus cells).

• No cytologic atypia – Malignant glomus tumor is exceptionally rare; presence of atypia, necrosis, or mitoses should raise suspicion.

5. NAMING LOGIC & TERMINOLOGY

• Glomus – From Latin glomus meaning ball or ball of yarn – referring to the spherical, convoluted structure of the normal glomus body and the tumor.

• Glomangioma – Glomus tumor with prominent vascular component (angio = vessel, oma = tumor).

• Glomangiomyoma – Glomus tumor with prominent smooth muscle component (myo = muscle).

• Sucquet–Hoyer canal – Named after the anatomists who described the normal glomus body channels.

• Hildreth sign – Named after the surgeon who described the tourniquet test.

6. STAINING & MARKERS

H&E: Diagnostic in most cases, as described above.

Immunohistochemistry (essential for diagnosis in difficult cases or to rule out mimics):

• Smooth muscle actin (SMA): Strong, diffuse cytoplasmic positivity in glomus cells (they are modified smooth muscle cells). This is the most sensitive and specific marker.

• Calponin: Positive (smooth muscle marker).

• h-Caldesmon: Positive (smooth muscle marker; helps distinguish from myopericytoma which is h-caldesmon negative).

• Collagen type IV: Highlights the basement membrane surrounding individual glomus cells (chicken-wire pattern).

• Vimentin: Positive (mesenchymal origin).

• CD31 and CD34: Positive in endothelial cells lining vascular spaces (negative in glomus cells).

• Desmin: Usually negative or weakly positive (in contrast to leiomyoma, which is strongly desmin positive).

• Cytokeratin (CK7, AE1/AE3): Negative (excludes epithelial tumors).

• S100: Negative (excludes melanoma, schwannoma, and neurofibroma).

• GLMN immunohistochemistry: Reduced or absent expression in familial glomuvenous malformations (research).

Special stains:

• PAS (periodic acid–Schiff): Highlights the basement membrane around glomus cells (positive).

• Masson trichrome: Glomus cells stain red (muscle) and collagen stains blue.

Why SMA is critical: Glomus cells are modified smooth muscle cells; SMA positivity confirms the diagnosis and distinguishes glomus tumor from hemangioma (SMA negative in endothelial cells), neurogenic tumors (S100 positive), and epithelial tumors (cytokeratin positive).

7. TEMPORAL EVOLUTION

• Early tumor: Small, microscopic nodule of glomus cells around a few vascular channels; asymptomatic or minimal pain.

• Established tumor: Well-circumscribed, encapsulated nodule, 2–10 mm in diameter (subungual tumors are often smaller than 5 mm). Classic pain triad appears.

• Late tumor (long-standing): May erode the underlying distal phalanx (seen on radiograph as a well-defined, smooth cortical lucency). Compression of nail bed causes nail dystrophy (longitudinal erythronychia, ridging, or splitting).

• No progression to malignancy in the vast majority. Malignant glomus tumor (glomangiosarcoma) arises de novo or from pre-existing benign tumor (exceptionally rare). Histologic features of malignancy: marked cytologic atypia, increased mitotic activity (exceeding 5 mitoses per 50 high-power fields), necrosis, and deep invasion.

8. PATTERN RECOGNITION & DIAGNOSTIC LOGIC

• Pattern (subungual location): Well-circumscribed, encapsulated dermal nodule composed of uniform round cells with pale eosinophilic cytoplasm and round nuclei, surrounding vascular spaces.

Diagnostic pathway (integrating histology, IHC, and clinical features):

• Subungual tumor + SMA positive + S100 negative + cytokeratin negative + clinical triad → Glomus tumor.

• Subungual tumor + S100 positive + SOX10 positive + HMB45 positive → Subungual melanoma.

• Subungual tumor + CD31 positive (endothelial cells) + SMA negative (glomus cells absent) → Hemangioma.

• Subungual tumor + S100 positive + GFAP positive + neurofilament positive → Schwannoma or neurofibroma.

• Subungual tumor + GLMN mutation + multiple tumors + family history → Familial glomuvenous malformation.

• Subungual tumor + cytologic atypia + mitoses exceeding 5 per 50 high-power fields + necrosis → Malignant glomus tumor (glomangiosarcoma) .

Key discriminator from other painful subungual tumors:

• Glomus tumor: SMA positive, uniform glomus cells, vascular spaces, pain triad, Hildreth sign positive.

• Neuroma (traumatic): S100 positive, haphazard arrangement of axons and Schwann cells, history of nerve injury, Tinel sign positive.

• Subungual exostosis: Radiograph shows bony outgrowth; histology shows bone and cartilage; no glomus cells.

9. CLINICO-PATHOLOGICAL CORRELATION

• Paroxysmal pain (especially nocturnal) → Tumor innervation by unmyelinated C-fibers; vasomotor fluctuations during sleep (peripheral vasodilation) increase tumor volume and compress nerves.

• Point tenderness (Love test) → Tumor is encapsulated and small (2–5 mm); even pinpoint pressure deforms the capsule onto nerve endings.

• Cold hypersensitivity → Cold induces vasoconstriction of tumor vessels → ischemia → release of pain mediators (substance P, prostaglandins).

• Hildreth sign (pain relieved by proximal compression) → Ischemic compression of the digital artery reduces blood flow to the tumor → tumor shrinks (less vascular engorgement) → decompresses nerve endings.

• Longitudinal erythronychia (red streak in nail) → Tumor compresses the nail bed or nail matrix, causing localized thinning of the nail plate and visualization of the underlying vascular tumor.

• Bluish discoloration visible through nail → Tumor contains dilated vascular spaces filled with deoxygenated blood.

• Nail plate ridging or splitting → Long-standing compression of the nail matrix disturbs nail plate formation.

• Radiographic lucency of distal phalanx → Chronic pressure erosion of bone (benign, smooth, well-corticated defect).

10. EXAM-FOCUSED INSIGHTS

• Subungual glomus tumor is the most common glomus tumor in the body – 75% occur in the hand, most under the nail.

• Classic triad (pain, tenderness, cold sensitivity) is pathognomonic – If a patient presents with all three, the diagnosis is glomus tumor until proven otherwise.

• Hildreth sign is board gold – Pain relief with proximal compression (tourniquet effect) is highly specific. Know this for oral boards.

• SMA is the diagnostic IHC marker – Glomus cells are modified smooth muscle cells; SMA positivity confirms the diagnosis.

• Tiny tumor size (often <5 mm) makes clinical diagnosis challenging – Many patients are misdiagnosed with paronychia, neuroma, or arthritis for years.

• MRI is the best imaging modality – Glomus tumor shows low T1 signal, high T2 signal (due to vascular spaces), and intense contrast enhancement.

• Complete surgical excision is curative – Recurrence (10–20%) is due to incomplete excision, not aggressive biology.

• Do NOT mistake glomus tumor for hemangioma – Hemangioma lacks glomus cells (SMA negative in endothelial cells; SMA positive only in pericytes which are sparse). IHC distinguishes.

• Malignant glomus tumor is exceptionally rare – Do not overcall. Atypical features (pleomorphism, mitoses) require expert pathology review.

• Multiple glomus tumors (familial) are glomuvenous malformations – Associated with GLMN mutations; often less painful and more widespread.

• Subungual melanoma can mimic glomus tumor – Pigmentation (Hutchinson sign) is the key clinical clue. Biopsy any non-pigmented painful subungual nodule without a classic history.

Must-Know Board Exam Questions & Answers

Q1: A 45-year-old woman presents with severe, lancinating pain in the left thumb that awakens her at night. The nail shows a longitudinal red streak. Touching the nail with a pinhead reproduces the pain. What is the most likely diagnosis?

A: Subungual glomus tumor.

Q2: What are the three components of the classic clinical triad of glomus tumor?

A: Paroxysmal pain (often nocturnal), extreme point tenderness, and cold hypersensitivity.

Q3: A patient with suspected subungual glomus tumor has immediate relief of pain when a tourniquet is applied to the proximal digit. What is this sign called, and what does it indicate?

A: Hildreth sign. It is highly specific for glomus tumor and indicates that vascular engorgement of the tumor contributes to pain.

Q4: What is the most sensitive and specific immunohistochemical marker for glomus tumor?

A: Smooth muscle actin (SMA) – glomus cells are modified smooth muscle cells and show strong, diffuse cytoplasmic positivity.

Q5: A subungual nodule is biopsied. Histology shows a well-circumscribed, encapsulated dermal nodule composed of uniform round cells with pale eosinophilic cytoplasm surrounding dilated vascular channels. No cytologic atypia is seen. What is the diagnosis?

A: Glomus tumor (solid variant).

Q6: What is the expected recurrence rate after surgical excision of a subungual glomus tumor, and why does recurrence occur?

A: 10–20%. Recurrence is due to incomplete excision (tumor is small, encapsulated, and often poorly visualized through the nail bed).

Q7: What imaging modality is best for preoperative localization of a subungual glomus tumor, and what are the characteristic findings?

A: MRI (magnetic resonance imaging). Glomus tumor shows low signal on T1-weighted images, high signal on T2-weighted images (due to vascular spaces), and intense gadolinium enhancement.

Q8: A patient presents with multiple painful blue nodules on the digits and trunk since childhood. Family history reveals an autosomal dominant pattern. What gene is likely mutated?

A: GLMN (glomulin) on chromosome 1p21-22, causing familial glomuvenous malformations (multiple glomus tumors).

Q9: What histologic features would raise concern for malignant glomus tumor (glomangiosarcoma)?

A: Marked cytologic atypia (pleomorphism), increased mitotic activity (exceeding 5 mitoses per 50 high-power fields), necrosis, and deep invasion.

Q10: A 60-year-old man presents with a painful, pigmented subungual lesion with Hutchinson sign (pigmentation extending onto the proximal nail fold). What is the most likely diagnosis, and what IHC markers would confirm it?

A: Subungual melanoma. Confirm with S100, SOX10, HMB45, and Melan-A (all positive in melanoma; negative in glomus tumor).